Trials / Unknown
UnknownNCT01770067
Salvage of Infected Cardiovascular Implantable Electronic Devices (CIED) by Localized High-dose Antibiotics
Prospective Evaluation of the Efficacy and Safety of Continuous In-situ Ultra High-dose Antibiotics (CITA) and Minimally Invasive Surgery (MIS) Utilizing Regulated Negative Pressure-assisted Wound Therapy (RNPT) in the Salvage of Infected Cardiovascular Implantable Electronic Devices (CIED) by Localized High-dose Antibiotics
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Following previous positive experience with regulated CITA-RNPT of infected CIEDs, we suggest increasing the number of recruited patients and that CITA-RNPT can be administered prophylactically to patients prior to replacement of previously treated CIEDs, immuno-compromised patients, and others.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CITA-RNPT | |
| PROCEDURE | Extraction of infected CIED |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2013-01-17
- Last updated
- 2022-02-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01770067. Inclusion in this directory is not an endorsement.